As of November 2024, Chengdu Olymvax Biopharmaceuticals has a market cap of $476.10M. This makes Chengdu Olymvax Biopharmaceuticals the world's 11700th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $513.38M | -43.35% |
2023 | $906.31M | 13.91% |
2022 | $795.60M | -61.27% |
2021 | $2.05B | - |